Literature DB >> 1748882

Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo.

C J Wikstrand1, X M He, G N Fuller, S H Bigner, P Fredman, L Svennerholm, D D Bigner.   

Abstract

Monoclonal antibodies (MAb; DMAb, monoclonal antibodies derived at Duke Medical Center) directed against the oncofetally expressed lactotetraosyl gangliosides 3'-isoLM1 (IV3NeuAc-LcOse4Cer) and 3',6'-isoLD1 (IV3NeuAc,III6NeuAc-LcOse4Cer) were produced and their reactivity spectra compared to that of the alpha-3'-isoLM1 MAb SL-50. The IgM MAb SL-50 defines the epitope NeuAc (or NeuGc)alpha 2-3Gal beta 1-3GlcNAc, the terminal sequence of both gangliosides. SL-50 requires an unsubstituted GlcNAc residue; IgM DMAb-14 will accept the alpha 2-6 linked sialic acid to GlcNAc found in 3',6'-isoLD1. Immunohistochemical localization of 3'-isoLM1 was performed on 31 biopsy specimens of human gliomas; 15 (48%) expressed 3'-isoLM1 as defined by binding of MAb SL-50. Staining of small anaplastic cells, giant cells, and the glial component of gliosarcomas was observed. Neoplastic gemistocytes, when present, showed particularly intense staining. The 3'-isoLM1 and 3',6'-isoLD1 distribution in cultured cell lines and derived xenografts of primary tumors of the human central nervous system and of embryonal or neuroectodermal tumor derivation was determined. Six of 29 cell lines expressed 3'-isoLM1: 2/16 gliomas, 3/3 teratomas, 1/1 pancreatic adenocarcinoma. No cell line expressed detectable 3',6'-isoLD1 by immunostain analysis of ganglioside extracts. The 3'-iso-LM1-positive cell lines expressed it in xenograft form; in five xenografts, the corresponding cell lines of which were 3'-isoLM1-negative, it was a proportion of the monosialoganglioside fraction. 3',6'-isoLD1 was detected in two xenografts, D-54 MG (glioma) and PA-1 (teratoma). The demonstration of 3'-isoLM1 in gliomas in in vivo forms and the relatively infrequent expression by derived cultured cells suggest that ganglioside expression is modified by environmental forces. Expression of 3'-isoLM1 and 3',6'-isoLD1 in fetal and neonatal brain, in intense reactive astrocytosis such as polyunsaturated fatty acid lipidosis, and in primary neoplasms of the central nervous system suggests their role in cell-cell attachment during development, migration, and neoplastic transformation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748882     DOI: 10.1097/00005072-199111000-00007

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  12 in total

1.  Plasma membrane-associated glycohydrolases activation by extracellular acidification due to proton exchangers.

Authors:  Massimo Aureli; Nicoletta Loberto; Rosaria Bassi; Anita Ferraretto; Silvia Perego; Patrizia Lanteri; Vanna Chigorno; Sandro Sonnino; Alessandro Prinetti
Journal:  Neurochem Res       Date:  2012-02-23       Impact factor: 3.996

2.  Evaluation of anti-podoplanin rat monoclonal antibody NZ-1 for targeting malignant gliomas.

Authors:  Yukinari Kato; Ganesan Vaidyanathan; Mika Kato Kaneko; Kazuhiko Mishima; Nidhi Srivastava; Vidyalakshmi Chandramohan; Charles Pegram; Stephen T Keir; Chien-Tsun Kuan; Darell D Bigner; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2010-10       Impact factor: 2.408

3.  In vivo growth conditions suppress the expression of ganglioside GM2 and favour that of lacto series gangliosides in the human glioma D-54MG cell line.

Authors:  P Fredman; C J Wikstrand; J E Månsson; G Reifenberger; S H Bigner; A Rasheed; L Svennerholm; D D Bigner
Journal:  Glycoconj J       Date:  1996-06       Impact factor: 2.916

4.  1H NMR ganglioside ceramide resonance region on the differential diagnosis of low and high malignancy of brain gliomas.

Authors:  V Lombardi; L Valko; M Valko; A Scozzafava; H Morris; M Melnik; J Svitel; M Budesinský; J Pelnár; J Steno; T Liptaj; L Zalibera; J Budinská; J Zlatos; A Giuliani; L Mascolo; D Leibfritz; A Troncone; F Marzullo; M Mazur; J Klener; E Zverina
Journal:  Cell Mol Neurobiol       Date:  1997-10       Impact factor: 5.046

5.  Development of lacto-series ganglioside fluorescent probe using late-stage sialylation and behavior analysis with single-molecule imaging.

Authors:  Maina Takahashi; Naoko Komura; Yukako Yoshida; Eriko Yamaguchi; Ami Hasegawa; Hide-Nori Tanaka; Akihiro Imamura; Hideharu Ishida; Kenichi G N Suzuki; Hiromune Ando
Journal:  RSC Chem Biol       Date:  2022-05-31

6.  Multiple phenotypic changes in mice after knockout of the B3gnt5 gene, encoding Lc3 synthase--a key enzyme in lacto-neolacto ganglioside synthesis.

Authors:  Chien-Tsun Kuan; Jinli Chang; Jan-Eric Mansson; Jianjun Li; Charles Pegram; Pam Fredman; Roger E McLendon; Darell D Bigner
Journal:  BMC Dev Biol       Date:  2010-11-18       Impact factor: 1.978

7.  GMab-1, a high-affinity anti-3'-isoLM1/3',6'-isoLD1 IgG monoclonal antibody, raised in lacto-series ganglioside-defective knockout mice.

Authors:  Yukinari Kato; Chien-Tsun Kuan; Jinli Chang; Mika Kato Kaneko; Joanne Ayriss; Hailan Piao; Vidyalakshmi Chandramohan; Charles Pegram; Roger E McLendon; Pam Fredman; Jan-Eric Månsson; Darell D Bigner
Journal:  Biochem Biophys Res Commun       Date:  2009-11-26       Impact factor: 3.575

Review 8.  Ganglioside modulation of the PDGF receptor. A model for ganglioside functions.

Authors:  A J Yates; H E Saqr; J Van Brocklyn
Journal:  J Neurooncol       Date:  1995       Impact factor: 4.130

9.  Affinity-matured recombinant immunotoxin targeting gangliosides 3'-isoLM1 and 3',6'-isoLD1 on malignant gliomas.

Authors:  Hailan Piao; Chien-Tsun Kuan; Vidya Chandramohan; Stephen T Keir; Charles N Pegram; Xuhui Bao; Jan-Eric Månsson; Ira H Pastan; Darell D Bigner
Journal:  MAbs       Date:  2013-07-25       Impact factor: 5.857

10.  The SPPL3-Defined Glycosphingolipid Repertoire Orchestrates HLA Class I-Mediated Immune Responses.

Authors:  Marlieke L M Jongsma; Antonius A de Waard; Matthijs Raaben; Tao Zhang; Birol Cabukusta; René Platzer; Vincent A Blomen; Anastasia Xagara; Tamara Verkerk; Sophie Bliss; Xiangrui Kong; Carolin Gerke; Lennert Janssen; Elmer Stickel; Stephanie Holst; Rosina Plomp; Arend Mulder; Soldano Ferrone; Frans H J Claas; Mirjam H M Heemskerk; Marieke Griffioen; Anne Halenius; Hermen Overkleeft; Johannes B Huppa; Manfred Wuhrer; Thijn R Brummelkamp; Jacques Neefjes; Robbert M Spaapen
Journal:  Immunity       Date:  2020-12-02       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.